Table 1.
Demographic and clinical characteristics of allergic rhinitis patients (n = 121).
| Characteristics | n | % |
|---|---|---|
| Gender | ||
| Male | 44 | 36.4 |
| Female | 77 | 63.6 |
| Current age (average ± SD: 34.2 ± 11.8, median: 31.0, range: 18–69) | ||
| < 20 years | 3 | 2.5 |
| 20–29 years | 52 | 43.0 |
| 30–39 years | 31 | 25.6 |
| 40–49 years | 19 | 15.7 |
| > 49 years | 16 | 13.2 |
| Environmental conditions | ||
| Smoking | 11 | 9.1 |
| Pet in the household | 50 | 41.3 |
| Family history with allergic diseases | ||
| No | 60 | 49.6 |
| Allergic conjunctivitis | 1 | 0.8 |
| Allergic rhinitis | 36 | 29.8 |
| Asthma | 9 | 7.4 |
| Food allergy | 3 | 2.5 |
| More than one allergic disease | 12 | 9.9 |
| Age of onset (average ± SD: 18.5 ± 15.4, median: 15.0, range: 0.5–59) | ||
| < 1 year | 4 | 3.3 |
| 1–9 years | 40 | 33.1 |
| 10–19 years | 20 | 16.5 |
| 20–29 years | 29 | 24.0 |
| 30–39 years | 14 | 11.6 |
| > 39 years | 14 | 11.6 |
| Severity symptoms | ||
| Mild intermittent | 35 | 28.9 |
| Moderate to severe intermittent | 19 | 15.7 |
| Mild persistent | 13 | 10.7 |
| Moderate to severe persistent | 54 | 44.6 |
| Current medications | ||
| No | 29 | 24.0 |
| AH | 21 | 17.4 |
| IC | 12 | 9.9 |
| AH, IC | 58 | 47.9 |
| AH, IC, NI | 1 | 0.8 |
| Comorbidities | ||
| No | 81 | 66.9 |
| Atopic dermatitis/atopic eczema | 3 | 2.5 |
| Allergic rhinitis | 9 | 7.4 |
| Allergic rhinoconjunctivitis | 4 | 3.3 |
| Asthma | 1 | 0.8 |
| Food allergy | 2 | 1.7 |
| Obstructive sleep apnea | 5 | 4.1 |
| Two comorbidities | 11 | 9.1 |
| More than two comorbidities | 5 | 4.1 |
AH, antihistamine; IC, intranasal corticosteroid; LA, leukotriene antagonist; IT, immunotherapy.